PALIPERIDONA STADA 75mg extended release injectable suspension in prefilled syringe medication leaflet

N05AX13 paliperidone • Nervous system | Antipsychotics | Other antipsychotics

Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.

The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.

Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.

General data about PALIPERIDONA STADA 75mg

Substance: paliperidone

Date of last drug list: 01-07-2024

Commercial code: W70359001

Concentration: 75mg

Pharmaceutical form: extended release injectable suspension in prefilled syringe

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: STADA ARZNEIMITTEL AG - GERMANIA

Holder: STADA M&D S.R.L. - ROMANIA

Number: 15501/2024/01

Shelf life: 3 years

Concentrations available for paliperidone

1000mg, 100mg, 12mg, 150mg, 175mg, 25mg, 263mg, 350mg, 3mg, 50mg, 525mg, 6mg, 700mg, 75mg, 9mg